These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 4735188)

  • 1. Comparison of anticoagulant activity of two preparations of purified heparin.
    Baltes BJ; Diamond S; D'Agostino RJ
    Clin Pharmacol Ther; 1973; 14(2):287-90. PubMed ID: 4735188
    [No Abstract]   [Full Text] [Related]  

  • 2. Anticoagulant activity of two commercially available heparin preparations. A controlled study.
    Gomez-Perez F
    J Clin Pharmacol New Drugs; 1972 Oct; 12(10):413-6. PubMed ID: 4484532
    [No Abstract]   [Full Text] [Related]  

  • 3. Anticoagulant activity of beef and hog mucosal heparins.
    Aiach M; Kher A; Michaud A; Mardiguian J; Trillou M; Leclerc M
    Thromb Res; 1979 Jan; 14(1):167-77. PubMed ID: 371063
    [No Abstract]   [Full Text] [Related]  

  • 4. Heparin from bovine intestinal mucosa: glycans with multiple sulfation patterns and anticoagulant effects.
    Tovar AM; Capillé NV; Santos GR; Vairo BC; Oliveira SN; Fonseca RJ; Mourão PA
    Thromb Haemost; 2012 May; 107(5):903-15. PubMed ID: 22437650
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Anticoagulant activity of whale intestine heparin and its clinical application.
    Abe T; Kazama M; Matsuda M; Ikemori R; Shibata T
    Bibl Haematol; 1968; 29():1141-9. PubMed ID: 5750138
    [No Abstract]   [Full Text] [Related]  

  • 6. Anticoagulant activities of lung and mucous heparins.
    Barrowcliffe TW; Johnson EA; Eggleton CA; Thomas DP
    Thromb Res; 1978 Jan; 12(1):27-36. PubMed ID: 644557
    [No Abstract]   [Full Text] [Related]  

  • 7. The effect of heparin on the activated partial thromboplastin time.
    Triplett DA; Harms CS; Koepke JA
    Am J Clin Pathol; 1978 Sep; 70(3 Suppl):556-9. PubMed ID: 568381
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Variability of heparin preparations in clinical use.
    Jaques LB; Kavanagh LW
    Thromb Diath Haemorrh Suppl; 1973; 56():171-80. PubMed ID: 4142115
    [No Abstract]   [Full Text] [Related]  

  • 9. [Studies on the anticoagulant properties of natural protease inhibitors].
    Schulz K
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1967; 88(2):225-35. PubMed ID: 4174663
    [No Abstract]   [Full Text] [Related]  

  • 10. Comparison of activated recalcification and partial thromboplastin tests as controls of heparin therapy.
    Ray PK; Harper TA
    J Lab Clin Med; 1971 Jun; 77(6):901-7. PubMed ID: 5559859
    [No Abstract]   [Full Text] [Related]  

  • 11. Effect of lung and gut heparin on experimental arterial thrombosis.
    Kwaan HC; Hatem A
    Adv Exp Med Biol; 1975; 52():263-8. PubMed ID: 1124701
    [No Abstract]   [Full Text] [Related]  

  • 12. Anticoagulant activity of heparin: assay of bovine, human and porcine preparations by amidolytic and clotting methods.
    Teien AN; Abildgaard U; Höök M; Lindahl U
    Thromb Res; 1977 Aug; 11(2):107-17. PubMed ID: 905965
    [No Abstract]   [Full Text] [Related]  

  • 13. In vivo studies on the inhibition of coagulation by fractionated heparin and by a heparin analogue. II. Effects of a heparin analogue.
    Schmitz-Huebner U; Asbeck F; van de Loo J
    Thromb Haemost; 1981 Oct; 46(3):617-20. PubMed ID: 6797091
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Statistical correlation and heparin sensitivity of activated partial thromboplastin time, whole blood coagulation time, and an automated coagulation time.
    Schriever HG; Epstein SE; Mintz MD
    Am J Clin Pathol; 1973 Sep; 60(3):323-9. PubMed ID: 4728138
    [No Abstract]   [Full Text] [Related]  

  • 15. Dermatan sulfate and LMW heparin enhance the anticoagulant action of activated protein C.
    Fernández JA; Petäjä J; Griffin JH
    Thromb Haemost; 1999 Nov; 82(5):1462-8. PubMed ID: 10595639
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Plasma heparin: a simple, one-sample determination of both effect and concentration based on the activated partial thromboplastin time.
    Hoffman JJ; Meulendijk PN
    Clin Chim Acta; 1978 Aug; 87(3):417-24. PubMed ID: 679478
    [No Abstract]   [Full Text] [Related]  

  • 17. In vitro comparative study of the anticoagulant action of lung and gut heparin: part 1.
    Fukuda T; Tatsumi Y; Kimura Y; Maeda H; Okuda K
    Osaka City Med J; 1980; 26(1):19-37. PubMed ID: 7267090
    [No Abstract]   [Full Text] [Related]  

  • 18. [Influence of bigumal on the blood coagulation system and on the anticoagulant effect of heparin].
    kremneva VF; Ushkalova EA; Shcheglova NV
    Farmakol Toksikol; 1986; 49(6):43-5. PubMed ID: 3817142
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Heparins from porcine and bovine intestinal mucosa: Are they similar drugs?
    Aquino RS; Pereira MS; Vairo BC; Cinelli LP; Santos GR; Fonseca RJ; Mourão PA
    Thromb Haemost; 2010 May; 103(5):1005-15. PubMed ID: 20216993
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The heterogeneity of heparins.
    Lasker SE
    Fed Proc; 1977 Jan; 36(1):92-7. PubMed ID: 556607
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.